We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.26B
AUM Growth
+$740M
Cap. Flow
+$520M
Cap. Flow %
9.89%
Top 10 Hldgs %
40.34%
Holding
110
New
23
Increased
31
Reduced
29
Closed
25

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$178M
2
AGN
Allergan plc
AGN
+$168M
3
GILD icon
Gilead Sciences
GILD
+$89.7M
4
BABA icon
Alibaba
BABA
+$67.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$66.5M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$93.9M
2
BPMC
Blueprint Medicines
BPMC
+$77.2M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$73.7M
4
PFE icon
Pfizer
PFE
+$50.2M
5
ELV icon
Elevance Health
ELV
+$42.9M

Sector Composition

Rank Sector Weight
1 Healthcare 55.27%
2 Technology 8.75%
3 Communication Services 4%
4 Consumer Discretionary 3.22%
5 Financials 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
26
DexCom
DXCM
$28.4B
$61.7M 1.17%
+1,646,784
New +$51.8M
PYPL icon
27
PayPal
PYPL
$49.6B
$59.8M 1.14%
522,446
+14,847
+3% +$1.65M
VYGR icon
28
Voyager Therapeutics
VYGR
$185M
$57.6M 1.09%
2,117,388
+166,327
+9% +$3.81M
PFE icon
29
CALL
Pfizer
PFE
$141B
$57.3M 1.09%
+1,394,020
New +$55.4M
INTU icon
30
Intuit
INTU
$83.8B
$56.9M 1.08%
217,747
-34,792
-14% -$8.84M
DIS icon
31
Walt Disney
DIS
$168B
$55.7M 1.06%
+398,702
New +$52.9M
GDDY icon
32
GoDaddy
GDDY
$12.9B
$54.9M 1.04%
782,442
-291,975
-27% -$22M
IRTC icon
33
iRhythm Holdings
IRTC
$3.76B
$54M 1.03%
682,963
+140,930
+26% +$10.3M
MSFT icon
34
Microsoft
MSFT
$2.9T
$53.9M 1.02%
402,579
+106,279
+36% +$13.5M
NVRO
35
DELISTED
NEVRO CORP.
NVRO
$53.9M 1.02%
830,834
+109,605
+15% +$6.82M
ELV icon
36
Elevance Health
ELV
$82.2B
$53.4M 1.01%
189,219
-157,178
-45% -$42.9M
PGR icon
37
Progressive
PGR
$126B
$52.2M 0.99%
+653,485
New +$50.5M
EXAS
38
DELISTED
Exact Sciences
EXAS
$49.4M 0.94%
418,329
-148,030
-26% -$14.9M
OEF icon
39
PUT
iShares S&P 100 ETF
OEF
$19.8B
$47.9M 0.91%
+1,115,500
New +$143M
TMO icon
40
Thermo Fisher Scientific
TMO
$208B
$47.2M 0.9%
160,666
-120,770
-43% -$33.3M
TWTR
41
DELISTED
Twitter, Inc.
TWTR
$45M 0.85%
+1,288,027
New +$47.3M
TWLO icon
42
Twilio
TWLO
$29.6B
$43.1M 0.82%
316,142
+190,387
+151% +$25.4M
ALGN icon
43
Align Technology
ALGN
$12.2B
$42.5M 0.81%
155,459
-57,430
-27% -$17.3M
NYT icon
44
New York Times
NYT
$11.9B
$42.5M 0.81%
1,301,486
-426,365
-25% -$14.2M
NFLX icon
45
Netflix
NFLX
$296B
$38.8M 0.74%
1,056,390
+192,190
+22% +$6.93M
DERM
46
DELISTED
Dermira, Inc.
DERM
$38.7M 0.73%
4,044,542
+1,463,509
+57% +$15.8M
SE icon
47
Sea Limited
SE
$64.1B
$38.4M 0.73%
1,155,123
+147,154
+15% +$3.99M
PBYI icon
48
Puma Biotechnology
PBYI
$412M
$36.1M 0.69%
2,838,376
+234,456
+9% +$5.4M
XYZ
49
Block Inc
XYZ
$47.5B
$35.3M 0.67%
487,346
-88,252
-15% -$6.17M
WMGI
50
DELISTED
Wright Medical Group Inc
WMGI
$35.3M 0.67%
1,183,313
+273,123
+30% +$8.33M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2019 Portfolio in Review

As of Q2 2019, PFM Health Sciences held 110 positions worth $5.26B, up 16% from $4.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences deployed $520M of net new capital in Q2 2019, opening 23 new positions and adding to 31 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 2,079,388 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 55% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $93.9M trimmed.

  • PFM Health Sciences's largest Q2 2019 buy was BioMarin Pharmaceuticals: 2,079,388 shares worth $178M.
  • PFM Health Sciences added most to Allergan plc in Q2 2019, an estimated $168M increase.
  • PFM Health Sciences's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $93.9M.
  • PFM Health Sciences fully exited Blueprint Medicines in Q2 2019, selling an estimated $77.2M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $5.26B portfolio in Q2 2019.
  • PFM Health Sciences opened 23 new positions and closed 25 in Q2 2019.
  • PFM Health Sciences's portfolio value rose 16% quarter-over-quarter to $5.26B.

Based on PFM Health Sciences's 13F filing for Q2 2019, filed 14 Aug 2019.